News
Zacks Investment Research on MSN12h
Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock RisesQuest Diagnostics Inc.’s DGX second-quarter 2025 adjusted earnings per share (EPS) of $2.62 beat the Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback